Vascular Immunomother T Cell Lymphoma
1 clinical trials · Condition
◉ Watch Vascular Immunomother T Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL (NCT05627856) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-02-21 |
Track Vascular Immunomother T Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.